top of page
Search

Commencement of the Phase 1 Clinical Trial of VectorFlu™ ONE

  • hkubio2021
  • Mar 1, 2020
  • 1 min read

Phase 1 clinical trials of VectorFlu™ ONE, the world's first COVID-19 nasal vaccine, developed by the research team of HKU Department of Microbiology, commenced in March 2021 at the HKU Phase 1 Clinical Trials Centre.




 
 
bottom of page